Metabolic surgery gains ground in Brazil as diabetes prevalence doubles

Brazil's adult diabetes prevalence rose to 12.9% in 2024, more than doubling in under two decades, per the Vigitel survey. Metabolic surgery is being promoted as a key strategy for Type 2 Diabetes control and remission, though the item is a promotional piece from a surgeon's perspective, not a clinical trial or policy change. The significance lies in the public health burden and potential shift in treatment adoption.